News
Myrio Therapeutics awarded CUREator grant for pandemic preparedness research
31 May 2023, MELBOURNE, Australia – Australia’s sovereign pandemic preparedness has…
Myrio Therapeutics data published in Nature: unlocking new targets for antibody-based therapies
Myrio Therapeutics Pty Ltd (Myrio) today announced ground-breaking findings published in…
CoVIC consortium publishes Global study on variant-resistant SARS-CoV-2 epitopes in Science
Myrio is proud to be part of the global CoVIC consortium, providing antibodies in the…
CAR TCR Summit: Myrio Tx shares transformational approach to targeted human antibody-based therapies
Myrio Therapeutics (Myrio Tx) is driving a new frontier of antibody-based therapies as…